Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy

Clinical trial NCT01472510 · COMPLETED

Trial details

NCT number: NCT01472510
Sponsor: Vitreo-Retinal Associates, PC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2011-12-01
Primary completion: 2013-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.